Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review

JC Kovacic, S Dimmeler, RP Harvey, T Finkel… - Journal of the American …, 2019‏ - jacc.org
Endothelial to mesenchymal transition (EndMT) is a process whereby an endothelial cell
undergoes a series of molecular events that lead to a change in phenotype toward a …

Endothelial to mesenchymal transition in health and disease

Y Xu, JC Kovacic - Annual Review of Physiology, 2023‏ - annualreviews.org
The endothelium is one of the largest organ systems in the body, and data continue to
emerge regarding the importance of endothelial cell (EC) dysfunction in vascular aging and …

Aortic valve stenosis: from basic mechanisms to novel therapeutic targets

PR Goody, MR Hosen, D Christmann… - … , and vascular biology, 2020‏ - ahajournals.org
Aortic valve stenosis is the most prevalent heart valve disease worldwide. Although
interventional treatment options have rapidly improved in recent years, symptomatic aortic …

[HTML][HTML] Cathepsin S (CTSS) activity in health and disease-A treasure trove of untapped clinical potential

P Smyth, J Sasiwachirangkul, R Williams… - Molecular aspects of …, 2022‏ - Elsevier
Amongst the lysosomal cysteine cathepsin family of proteases, cathepsin S (CTSS) holds
particular interest due to distinctive properties including a normal restricted expression …

Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial

TA Pawade, MK Doris, R Bing, AC White, L Forsyth… - Circulation, 2021‏ - ahajournals.org
Background: Valvular calcification is central to the pathogenesis and progression of aortic
stenosis, with preclinical and observational studies suggesting that bone turnover and …

Spatiotemporal multi-omics map** generates a molecular atlas of the aortic valve and reveals networks driving disease

F Schlotter, A Halu, S Goto, MC Blaser, SC Body… - Circulation, 2018‏ - ahajournals.org
Background: No pharmacological therapy exists for calcific aortic valve disease (CAVD),
which confers a dismal prognosis without invasive valve replacement. The search for …

LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification

C Yu, L Li, F **e, S Guo, F Liu, N Dong… - Cardiovascular …, 2018‏ - academic.oup.com
Aims Emerging evidence indicates that long non-coding RNAs (lncRNAs) play a vital role in
cardiovascular physiology and pathology. Although the lncRNA TUG1 is implicated in …

Identification of immune-associated genes in diagnosing aortic valve calcification with metabolic syndrome by integrated bioinformatics analysis and machine learning

Y Zhou, W Shi, D Zhao, S **ao, K Wang… - Frontiers in …, 2022‏ - frontiersin.org
Background Immune system dysregulation plays a critical role in aortic valve calcification
(AVC) and metabolic syndrome (MS) pathogenesis. The study aimed to identify pivotal …

Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1

F Hadji, MC Boulanger, SP Guay, N Gaudreault… - Circulation, 2016‏ - ahajournals.org
Background: Calcific aortic valve disease is characterized by an abnormal mineralization of
the aortic valve. Osteogenic activity in the aortic valve is under the control of NOTCH1, which …

Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery

MA Rogers, E Aikawa - Nature Reviews Cardiology, 2019‏ - nature.com
Cardiovascular calcification is a health disorder with increasing prevalence and high
morbidity and mortality. The only available therapeutic options for calcific vascular and …